Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products
Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD
Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance
Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group
Big News Roundup: Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease; Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
